FreeFlow

What is FreeFlow?

FreeFlow is an early-stage venture firm dedicated to investing in human and planetary health companies propelled by deep tech solutions. Launched in 2019 with a focus on the entrepreneurial community at Caltech, FreeFlow tapped into core science breakthroughs, deep tech innovation, and a support system for founders.

Over four years, they invested in over 30 companies, leveraging proprietary IP, artificial intelligence (AI), machine learning (ML), and other advanced technologies to accelerate market entry and enhance efficiency. FreeFlow's tailored investment model includes sourcing high-potential, science-driven companies, often being the first venture investors, and providing post-investment support in non-science areas such as fundraising, marketing, hiring, and strategy. With $90M in assets under management across three funds, FreeFlow has shown an affinity for companies at the pre-seed, seed, Series A, and Series B stages that centralize computer science in their operations.

They have successfully fostered over 100 co-investment opportunities, conveying confidence amongst venture and corporate capital circles. FreeFlow also offers Special Purpose Vehicles (SPVs) for breakout firms in their portfolio.

The firm emphasizes the importance of advanced computing power, which drives precision and cross-disciplinary innovation from lab to field application. FreeFlow is committed to investing in companies that lead this convergence of science and technology. The firm's portfolio encapsulates transformative companies in both human health—like Iambic Therapeutics and StrokeDx—and planetary health—including Hydrosat and Captura.

Additionally, FreeFlow engages in community building through its 'Founder Sessions' content series, highlighting the journeys and insights of its portfolio company founders and leaders.